To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure access to Givinostat for families of children with Duchenne muscular dystrophy.
ITF Pharma UK, the United Kingdom marketing authorisation holder for givinostat, is providing access to givinostat through a type of compassionate use scheme called an Early Access Programme (EAP). Under the EAP, givinostat is free to both patients taking...
Givinostat